LEADER 02385nam  2200577   450 
001 9910788108603321
005 20200520144314.0
035   $a(CKB)2670000000613376
035   $a(EBL)2037820
035   $a(SSID)ssj0001539558
035   $a(PQKBManifestationID)11936600
035   $a(PQKBTitleCode)TC0001539558
035   $a(PQKBWorkID)11533172
035   $a(PQKB)10116226
035   $a(Au-PeEL)EBL2037820
035   $a(CaPaEBR)ebr11051878
035   $a(CaONFJC)MIL778444
035   $a(OCoLC)908192105
035   $a(MiAaPQ)EBC2037820
035   $a(PPN)193663414
035   $a(EXLCZ)992670000000613376
100   $a20150516h20152015  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aPersonalized epigenetics /$fTrygve O. Tollefsbol ; designer, Mark Rogers ; contributors, Vanessa Aguiar-Pulido [and forty five others]
210  1$aAmsterdam, Netherlands :$cAcademic Press,$d2015.
210  4$dİ2015
215   $a1 online resource (611 p.)
225 0 $aTranslational Epigenetics Series
300   $aDescription based upon print version of record.
311   $a0-12-800436-3 
311   $a0-12-420135-0 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $a6. BRAIN CELLULAR HETEROGENEITY AND METHYLATION VARIATION
330   $a Personalized Epigenetics discusses the core translatability of epigenetics to health management of individuals who have unique variations in their epigenetic signatures that can guide both disorder and disease prevention and therapy.    The book details inter-individual variability in the major epigenetic process in humans consisting of DNA methylation, histone modifications, and noncoding RNA, and the diagnostic, prognostic, and therapeutic potential of the field, it also reviews the impact of the environment on epigenetic variations among individuals and the role of pharmacology and drug de
606   $aEpigenetics
615  0$aEpigenetics.
676   $a572.865
700   $aTollefsbol$b Trygve O.$0603166
702   $aRogers$b Mark
702   $aAguiar-Pulido$b Vanessa
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910788108603321
996   $aPersonalized epigenetics$93777265
997   $aUNINA